At Houston Methodist, our teams are dedicated to the development of new treatments and therapies for such neurological challenges as stroke, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), myasthenia gravis, brain tumors, concussion, spinal disorders, brain aneurysms, arteriovenous malformations, moyamoya disease, stuttering, Tourette’s syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP).

We concentrate our investigations on meaningful translational research that broadens our understanding of the major neurological challenges of brain, pituitary tumors, brain microcirculation in normal and pathological conditions.